 | Angstrom Pharmaceuticals, Inc.Ångstrom's proprietary products target a clearly-defined pathway, the Urokinase Plasminogen Activation System (PA), which has repeatedly been shown in scientific literature to be directly involved in proliferative diseases, such as cancer and wet age-related macular degeneration (ARMD). |
 | CellzDirect, Inc.The mission of CellzDirect is to build a preeminent biotechnology company that develops innovative in vitro products and services and provides rapid, accurate data with valid interpretations to accelerate the discovery and development of bioavailable, safe and efficacious drugs. CellzDirect was sold to Invitrogen Corporationin 2008. |
 | HTG Molecular DiagnosticsHTG Molecular Diagnostics Inc. (HTG Molecular), established in 1997, is a privately held company with a corporate mission to develop a universal molecular biology-based tool set to improve the pharmaceutical drug discovery process. |
 | Regenesis Biomedical, Inc.Regenesis Biomedical, Inc. developed and markets the Provant® Wound Therapy System, the exciting new scientifically proven approach that is redefining the care of soft tissue wounds. |
